Advisor OS LLC Purchases 174 Shares of Gilead Sciences, Inc. (NASDAQ:GILD) dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
Gilead Sciences, Inc. (NASDAQ:GILD) Position Boosted by Mitsubishi UFJ Asset Management Co. Ltd. theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Cullen Frost Bankers Inc. Sells 606 Shares of Gilead Sciences, Inc. (NASDAQ:GILD) tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.
Metis Global Partners LLC Has $4.83 Million Position in Gilead Sciences, Inc. (NASDAQ:GILD) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Knuff & Co LLC Sells 3,800 Shares of Gilead Sciences, Inc. (NASDAQ:GILD) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Swiss National Bank trimmed its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 2.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,896,300 shares of the biopharmaceutical company’s stock after selling 115,900 shares during the period. Swiss […]
First Trust Direct Indexing L.P. Increases Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
MONECO Advisors LLC grew its stake in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 12.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 6,307 shares of the biopharmaceutical company’s stock after acquiring an additional 688 shares during the quarter. […]
Weaver C. Barksdale & Associates Inc. reduced its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 20.9% during the 4th quarter, HoldingsChannel.com reports. The fund owned 25,746 shares of the biopharmaceutical company’s stock after selling 6,786 shares during the quarter. Gilead Sciences makes up about 2.0% of Weaver C. Barksdale & Associates Inc.’s […]
Gilead Sciences (NASDAQ:GILD – Free Report) had its target price reduced by Barclays from $80.00 to $76.00 in a report issued on Monday, Benzinga reports. They currently have an equal weight rating on the biopharmaceutical company’s stock. Several other equities analysts have also recently weighed in on the stock. Truist Financial cut shares of Gilead […]